Skip to main content
. 2023 May 1;108(5):1201–1202. doi: 10.3324/haematol.2023.282874

Figure 1.

Figure 1.

Clearance studies of plasma-derived or recombinant factor VIII performed at the beginning of treatment in Patients 1 and 2. Figure adapted with permission from White et al. N Engl J Med 1989.